Lataa...

Cancer-testis antigens as biomarkers for Merkel cell carcinoma: Pitfalls and opportunities

BACKGROUND: The prognosis and treatment options for metastatic Merkel cell carcinoma (MCC) are poor. The immune-privileged status of cancer-testis (CT) antigens imparts tumor specificity, making them ideal candidates for targeted immunotherapy. We investigate the usefulness of the CT antigens SPA17...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cutan Pathol
Päätekijät: Dasgeb, Bahar, Mehregan, Darius, Ring, Christina, Nartker, Nathan, Brownell, Isaac
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8130841/
https://ncbi.nlm.nih.gov/pubmed/31218705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cup.13528
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!